SlideShare a Scribd company logo
A Comparison of Multimodal
Chromatographic Resins:
Protein Binding & Selectivity
Leslie S. Wolfe
Eric J. Suda
Carnley L. Norman
Sigma Mostafa
Abhinav A. Shukla
Process Development & Manufacturing
KBI Biopharma, Durham, NC
Overview
● Background
○ Mixed Mode Chromatography
○ Mixed Mode Resin characterization
● Comparison of Mixed Mode Resins
○ High throughput method for identifying optimal
operating ranges for mixed mode resins
○ Chromatography experiments to characterize HCP
and HMW removal
● Conclusions
2
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Mixed Mode Chromatography
● Takes advantage of more than one type of interaction
○ i.e. ionic, hydrophobic, hydrogen bonding
● Provides enhanced selectivity, “pseudo-affinity”
● Can reduce process steps
● Several mixed mode resins have recently been developed with:
○ Increased loading capacities
○ Higher ionic strength tolerance
GE Healthcare, CaptoTM
MMC ligand
Ionic interactions
Hydrophobic interactions
Hydrophobic interactions
GE Healthcare, CaptoTM
Adhere ligand
Ionic interactions
Capto is a registered trademark of GE Healthcare
3
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Mixed Mode Ligand Examples
Pall Corporation
NuviaTM
cPrimeTM
Bio-Rad Laboratories
Different mixed mode resins are available on the market and each could
potentially result in molecule specific performance (yield and selectivity)
EshmunoTM
HCX
EMD Millipore
CaptoTM
Adhere
GE Healthcare
MX-Trp-650M
Tosoh
CaptoTM
MMC
GE Healthcare
4
Capto is a registered trademark of GE Healthcare Capto is a registered trademark of GE Healthcare Nuvia and cPrime are registered trademarks
of Bio-Rad
TOYOPEARL is a registered trademark of Tosoh corporation Eshmuno is a registered trademark of Merck KGaA
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Mixed Mode Chromatography potential based on
previous work at KBI
● Demonstrated that mixed mode chromatography has the potential of
achieving superior selectivity by effectively exploiting multiple properties of a
target protein
● Previous work at KBI work focused on characterizing Capto MMC resin and
the use of mobile phase modulators to further enhance selectivity
○ Inclusion of Capto MMC into a mAb process was compared with and
without selective washes
○ Inclusion of a selective wash on Capto MMC resulted in higher product
purity
5
Wolfe, L., Barringer, C., Mostafa, S., Shukla, A. Multimodal chromatography: characterization of protein binding and
selectivity enhancement through mobile phase modulators, Journal of Chromatography A, 1340, 151-156, 2014.
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Effects of Modulators on Different Proteins
● Resin: Capto MMC
● Modulator added to equilibration, wash and elution
buffers
● Products eluted with a linear NaCl gradient
● Impact of modulator on retention was determined by the
NaCl concentration at peak maxima
6
Modulator Modulator Effect
MgCl2
, NaSCN, KI Decrease hydrophobic interactions
Ethanol, Methanol, Isopropanol Decrease hydrophobic interactions (used in low concentrations)
Urea, Sodium Thiocyanate Weakens hydrogen bonding, denaturant
Glycerol Weakens hydrophobic interactions
Ethylene Glycol Weakens hydrophobic interactions and hydrogen bonding
Arginine
Weakens hydrophobic interactions, induces protein unfolding, disrupts
electrostatic interactions
Ammonium Sulfate Strengthens hydrophobic interactions
Model Protein
RNase (pI 8.9)
Lysozyme (pI 9.6)
mAb1
mAb2
mAb3
mAb4
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
7
Effect of pH on Retention
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Log k’ vs. Log [NaCl]: Theory
log k’ = A – Blog(csalt
) + C(csalt
)
Melander, W.; El Rassi, Z.; Horvath, Cs. Journal of Chromatography, 469, 3-27, 1989.
The retention factor under isocratic conditions is represented by:
k’ = (tr
– tm
)/tm
tm
= time for mobile phase to pass through column
tr
= target protein retention time
Melander et. al described the dependency of the linear retention
factor on a mixed mode sorbent as a function of salt concentration as:
● Electrostatic interactions predominate: a linear relationship is expected between log k’ vs log[NaCl]
● Hydrophobic interactions predominate: a linear relationship is expected until a minimum is reached
at which point further increases in salt result in increased retention
8
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Log k’ vs. Log [NaCl]
RNase
● electrostatic
interactions
● No effect from urea
or ethylene glycol
All experiments
performed at
pH 7.0
Lysozyme
● hydrophobic and
electrostatic
interactions
● urea has largest
effect
mAb1
● driven by electrostatic
interactions, hydrophobic
contribution
● Urea and arginine have the
largest effect
9
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Taking Advantage of Modulators
● Incorporation of modulators into process can help
increase selectivity and purity of product
● Combinations of modulators can further enhance
process step
● Goal: Utilize mobile phase modulators to decrease
HCP levels during Capto MMC process step for
antibody purification
10
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Incorporation of a
process step utilizing a
modulator wash can
improve overall process
HCP clearance
baseline
12
Overview
● Background
○ Mixed Mode Chromatography
○ Mixed Mode Resin characterization
● Comparison of Mixed Mode Resins
○ High throughput method for identifying optimal
operating ranges for mixed mode resins
○ Chromatography experiments to characterize HCP
and HMW removal
● Conclusions
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Mixed Mode Chromatography & KBI’s mAB Purification Process Platform
● Mixed Mode resins are ideal for KBI’s mAb platform process since by the nature of our business
there is a significant diversity in mammalian cell clones/cell culture harvest and mAbs
● Mixed mode resins can provide added robustness to a mAb platform to reduce both HMW and HCP
impurities
● Given the complexity of mixed mode resin interactions, optimizing a mixed mode chromatography
step can be time consuming and potentially material limiting
13
DS
Process
Platform
Cell Line
Diversity
Media/feed
type diversity
HCP level
variability
Cell Density
variability
HMW level
variability
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Objectives
● Determine if there is at least one mixed mode cation exchange/hydrophobic
interaction polishing step resin that performs well for multiple mAbs
○ Ideal candidates for a mAb process platform
● Present a high throughput, low material requirement method for identifying
optimal operating ranges for multiple mixed mode resins in a single set of
experiments
○ Show how the method can be use to identify optimal chromatography
conditions
● Show the relationship between the high throughput screening data and
chromatography performance for different mAbs
14
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Mixed-mode cation exchange/hydrophobic interaction resins
15
NuviaTM
cPrimeTM
Bio-Rad Laboratories
MX-Trp-650M
Tosoh
EshmunoTM
HCX
EMD Millipore
CaptoTM
MMC
GE Healthcare
TM
16
Overview
● Background
○ Mixed Mode Chromatography
○ Mixed Mode Resin characterization
● Comparison of Mixed Mode Resins
○ High throughput method for identifying optimal
operating ranges for mixed mode resins
○ Chromatography experiments to characterize HCP
and HMW removal
● Conclusions
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
High Throughput Screening: Plate Experimental Design
Variable Conditions Evaluated
Load pH 4, 5, 6, 7, 8
Elution pH 4, 5, 6, 7, 8
Elution [NaCl] (M) 0.20, 0.65, 1.10, 1.55, 2.00
Three mAbs evaluated under a series of
conditions
● One plate executed per load pH
17
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
18
● The low yield process condition zone size varies
significantly with respect to resin, mAbs and
process conditions and are easily identifiable
● In general, Capto MMC has slightly larger low
yield zones for the mAbs and test conditions
within our typical operating pH range .
● In general, each resin has a characteristic
surface response map profile
19
Overview
● Background
○ Mixed Mode Chromatography
○ Mixed Mode Resin characterization
● Comparison of Mixed Mode Resins
○ High throughput method for identifying optimal
operating ranges for mixed mode resins
○ Chromatography experiments to characterize HCP
and HMW removal
● Conclusions
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Chromatography Experiments
● Goal: Compare resin ability to reduce HCP and HMW levels at multiple pHs
● Linear gradient studies executed at pH 5, 6 and 7
○ Product eluted from 0-2M NaCl
○ Each 1/8th
CV fractions collected
○ Analyzed fractions by SEC-HPLC for high molecular weight species (HMW)
■ Fractions containing cumulative yield 20%-80% pooled to reduce sample
numbers
■ Fractions containing high %LMW were excluded from the cumulative yield vs.
cumulative purity analysis
● Fractions containing 0 – 80% product yield after SEC-HPLC analysis were pooled for host
cell protein (HCP) analysis
20
Neutralized Protein A pools used for experiments
mAb Feed %HMW Feed HCP Level (ppm)
mAb1 ~1% 4,395
mAb2 ~4% 135
mAb3 ~8% 3,689
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Chromatography Experiments: Elution [NaCl] & elution peak volume data
21
● In general, Capto MMC and Eshmuno HCX
resulted in higher elution volumes
● Nuvia cPrime elution volume changes significantly
when pH increases from pH 5.0 to 6.0
∞ = target protein did not elute during NaCl gradient
● As expected, elution [NaCl] decreases with
increasing pH
● Capto MMC and Eshmuno HCX require
higher elution [NaCl] at each elution pH
● Tosoh MX-Trp had the lowest elution [NaCl]
at each pH and did not vary as much with
respect to pH
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Cumulative Yield vs. Cumulative HMW
mAb Feed %HMW
mAb1 ~1%
mAb2 ~4%
mAb3 ~8%
mAb1, pH 5.0
mAb2, pH 5.0
mAb3, pH 5.0
mAb1, pH 6.0
mAb2, pH 6.0
mAb3, pH 6.0
mAb1, pH 7.0
mAb2, pH 7.0
mAb3, pH 7.0
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
HCP Reduction
● Not all experiments yielded 80%
product in eluate fractions (*).
○ Capto MMC at pH 5.0 did not
yield any product for the 3 mAbs
tested
○ mAb 3 only achieved 80% yield in
6 of the 12 conditions tested
● HCP clearance is mAb specific with
conditions tested.
○ The greatest HCP reduction
consistently achieved across the
experiments is with mAb 1
mAb Feed HCP Level (ppm)
mAb1 4,395
mAb2 135
mAb3 3,689
** * ** ** *
23
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Summary Results – Optimization Factor
Resin
mAb 1 Optimization Factor
(Max. Yield * %HMW Red. * %HCP Red.)
mAb 2 Optimization Factor
(Max. Yield * %HMW Red. * %HCP Red.)
mAb 3 Optimization Factor
(Max. Yield * %HMW Red. * %HCP Red.)
pH 5.0
Capto MMC N/A* N/A* N/A*
Nuvia cPrime 0.81 0.32 N/A**
Eshmuno 0.39 N/A** N/A**
MX-Trp 0.08 N/A** N/A**
pH 6.0
Capto MMC 0.44 0.04 0.39
Nuvia cPrime 0.51 0.26 0.33
Eshmuno 0.08 -0.15 N/A**
MX-Trp -0.21 0.11 0.07
pH 7.0
Capto MMC 0.47 0.33 0.31
Nuvia cPrime 0.36 0.22 0.08
Eshmuno 0.29 0.65 N/A**
MX-Trp -0.03 0.01 0.14
*mAb did not elute from Capto MMC at pH 5.0 in up to 2M NaCl
**Not tested as 80% yield was not achieved
24
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Findings regarding the relationship between HT filter plate &
chromatography data
● High throughput filter plate data can be used to quickly
limit the focus of a chromatography evaluation using
minimal amounts of the target protein
○ pH and NaCl conditions not favorable for high yields
are easily identifiable
● There is a correlation between yield variability for each
condition (load pH and elution pH) and monomer
selectivity
○ more variability leads to better selectivity
25
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Best resins for each measure & overall performance based
on the chromatography experiment results
26
● There is not one best resin for all mAbs and conditions evaluated
● For each mAb, the best resin for each performance measure varies
● Nuvia cPrime provides good overall performance for all mAbs tested
● Tosoh MX-Trp consistently had low “optimization factor” scores for all of the mAbs and
conditions tested
*Conclusion will change based on the relative importance of each factor.
Molecule
Best resins based on
yield
Best resins based on
HMW reduction
Best resins based on
HCP reduction
Overall best resin based on
optimization factor
mAb1
Capto MMC
Tosoh MX-Trp
Nuvia cPrime
Capto MMC
Eshmuno HCX
Capto MMC
Nuvia cPrime
Capto MMC
mAb2
Capto MMC
Tosoh MX-Trp
Eshmuno HCX
Nuvia cPrime
Eshmuno HCX
Capto MMC
Eshmuno HCX
Nuvia cPrime
mAb3
Tosoh MX-Trp
Nuvia cPrime
Capto MMC
Eshmuno HCX
Capto MMC
Tosoh MX-Trp
Capto MMC
Nuvia cPrime
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Conclusions
● Demonstrated that a high throughput filter plate method can be used as an
efficient approach in screening chromatography resins and identifying their
optimal process conditions
○ Can assess within a short time period if a resin is suitable for purifying a
specific molecule using minimal protein
○ Narrows the focus of chromatography experimental conditions
● Each resin evaluated has its strengths
● Overall performance is based on selecting optimal operating conditions for each
resin and mAb combination
○ Nuvia cPrime provides good overall performance for all mAbs tested
○ Backup options will be needed to meet the unique challenges of each mAb
27
A Comparison of Multimodal Chromatographic Resins:
Protein Binding & Selectivity
Acknowledgments
• Eric Suda
• Abhinav Shukla, Ph.D.
• Sigma Mostafa, Ph.D.
• Carnley Norman, Ph.D.
• KBI Process Development Team
• KBI Analytical Development Team
28
www.kbibiopharma.com
PO Box 15579
1101 Hamlin Road
Durham, NC 27704
Tel: +1 919 479 9898
Contact Us
A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity

More Related Content

What's hot

Difference between HPLC and UPLC
Difference between HPLC and UPLCDifference between HPLC and UPLC
Difference between HPLC and UPLCVrushali Tambe
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY swagata's classroom
 
IMMUNOLOGICAL ASSAYS.pptx
IMMUNOLOGICAL ASSAYS.pptxIMMUNOLOGICAL ASSAYS.pptx
IMMUNOLOGICAL ASSAYS.pptxPandeyAjay1
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbDSneha Kadu
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Rakesh Kumar
 
Protein quantitation techniques
Protein quantitation techniquesProtein quantitation techniques
Protein quantitation techniquesGirish Kumar K
 
Photon Correlation Spectroscopy
Photon Correlation SpectroscopyPhoton Correlation Spectroscopy
Photon Correlation SpectroscopyDasari Mahalaxmi
 
Reverse phase chromatography
Reverse phase chromatographyReverse phase chromatography
Reverse phase chromatographyfaixan_live
 
Hplc (basic principles, operation and maintenance)
Hplc (basic principles, operation and maintenance)Hplc (basic principles, operation and maintenance)
Hplc (basic principles, operation and maintenance)alim125135
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatographyShavya Singh
 
Theory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography pptTheory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography pptshweta more
 
Hydrophobic interaction chromatography
Hydrophobic interaction chromatography Hydrophobic interaction chromatography
Hydrophobic interaction chromatography Taimoor Akhter Akhter
 

What's hot (20)

Process Scale Chromatography
Process Scale ChromatographyProcess Scale Chromatography
Process Scale Chromatography
 
GLP
GLPGLP
GLP
 
Difference between HPLC and UPLC
Difference between HPLC and UPLCDifference between HPLC and UPLC
Difference between HPLC and UPLC
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
 
IMMUNOLOGICAL ASSAYS.pptx
IMMUNOLOGICAL ASSAYS.pptxIMMUNOLOGICAL ASSAYS.pptx
IMMUNOLOGICAL ASSAYS.pptx
 
Analytical QbD
Analytical QbDAnalytical QbD
Analytical QbD
 
Hplc.ppt
Hplc.pptHplc.ppt
Hplc.ppt
 
Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)Hydrophobic interaction chromatography (1)
Hydrophobic interaction chromatography (1)
 
Hptlc
HptlcHptlc
Hptlc
 
Protein quantitation techniques
Protein quantitation techniquesProtein quantitation techniques
Protein quantitation techniques
 
Photon Correlation Spectroscopy
Photon Correlation SpectroscopyPhoton Correlation Spectroscopy
Photon Correlation Spectroscopy
 
H.P.L.C.
H.P.L.C.H.P.L.C.
H.P.L.C.
 
Reverse phase chromatography
Reverse phase chromatographyReverse phase chromatography
Reverse phase chromatography
 
Thin Layer Chromatography
Thin Layer ChromatographyThin Layer Chromatography
Thin Layer Chromatography
 
Hplc
Hplc Hplc
Hplc
 
Hplc (basic principles, operation and maintenance)
Hplc (basic principles, operation and maintenance)Hplc (basic principles, operation and maintenance)
Hplc (basic principles, operation and maintenance)
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Theory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography pptTheory of high performance liquid chromatography ppt
Theory of high performance liquid chromatography ppt
 
Chromatography,
Chromatography,Chromatography,
Chromatography,
 
Hydrophobic interaction chromatography
Hydrophobic interaction chromatography Hydrophobic interaction chromatography
Hydrophobic interaction chromatography
 

Viewers also liked

A Comparison of Multimodal Chromatography Resin: Case Study
A Comparison of Multimodal Chromatography Resin: Case StudyA Comparison of Multimodal Chromatography Resin: Case Study
A Comparison of Multimodal Chromatography Resin: Case StudyKBI Biopharma
 
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...KBI Biopharma
 
Evolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsEvolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsKBI Biopharma
 
KBI Case Studies: Process Development
KBI Case Studies: Process DevelopmentKBI Case Studies: Process Development
KBI Case Studies: Process DevelopmentKBI Biopharma
 
A Comparison of Protein A Chromatographic Stationary Phases
A Comparison of Protein A Chromatographic Stationary PhasesA Comparison of Protein A Chromatographic Stationary Phases
A Comparison of Protein A Chromatographic Stationary PhasesKBI Biopharma
 
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...KBI Biopharma
 
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...KBI Biopharma
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...KBI Biopharma
 
High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...KBI Biopharma
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...KBI Biopharma
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization KBI Biopharma
 
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...KBI Biopharma
 
TOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MTOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MRomain Dabre
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohGBX Summits
 
Managing Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a MoleculeManaging Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a MoleculeKBI Biopharma
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOKBI Biopharma
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingKBI Biopharma
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentKBI Biopharma
 
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...KBI Biopharma
 
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable SystemsScale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable SystemsKBI Biopharma
 

Viewers also liked (20)

A Comparison of Multimodal Chromatography Resin: Case Study
A Comparison of Multimodal Chromatography Resin: Case StudyA Comparison of Multimodal Chromatography Resin: Case Study
A Comparison of Multimodal Chromatography Resin: Case Study
 
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
Using Selective Washes to Solve a Purification Issue Involving a Host Cell Pr...
 
Evolution of mAb Downstream Platforms
Evolution of mAb Downstream PlatformsEvolution of mAb Downstream Platforms
Evolution of mAb Downstream Platforms
 
KBI Case Studies: Process Development
KBI Case Studies: Process DevelopmentKBI Case Studies: Process Development
KBI Case Studies: Process Development
 
A Comparison of Protein A Chromatographic Stationary Phases
A Comparison of Protein A Chromatographic Stationary PhasesA Comparison of Protein A Chromatographic Stationary Phases
A Comparison of Protein A Chromatographic Stationary Phases
 
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
Evaluation of Established & New Viral Filters for a Monoclonal Antibody Platf...
 
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
Optimization of Glycosyation & Charge Distribution Through Culture Parameters...
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
 
High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...
 
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
Debottlenecking Manufacturing Capacity: Initiating cell culture manufacturing...
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
Scalability of a Single-Use Bioreactor Platform for Biopharmaceutical Manufac...
 
TOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650MTOYOPEARL MX-Trp-650M
TOYOPEARL MX-Trp-650M
 
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit TosohDr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
Dr. Elke Prohaska & Regina Römling BioInnovation Leader Summit Tosoh
 
Managing Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a MoleculeManaging Raw Material Variability Over the Life-cycle of a Molecule
Managing Raw Material Variability Over the Life-cycle of a Molecule
 
Orphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMOOrphan Biopharmaceuticals & the CDMO
Orphan Biopharmaceuticals & the CDMO
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
 
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process DevelopmentHigh Throughput Bioreactor Mimetic in Early and Late Stage Process Development
High Throughput Bioreactor Mimetic in Early and Late Stage Process Development
 
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
Development of Analytical Control Strategies for L-DOS47, a Novel Antibody-En...
 
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable SystemsScale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
Scale-up & Tech Transfer from Non-disposable to Fully Disposable Systems
 

Similar to A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity

Prep Symposium | Poster July, 2013
Prep Symposium | Poster July, 2013Prep Symposium | Poster July, 2013
Prep Symposium | Poster July, 2013KBI Biopharma
 
Process Scale Chromatography
Process Scale ChromatographyProcess Scale Chromatography
Process Scale ChromatographyMilliporeSigma
 
Chromatographic Separation Tools Advantages and Disadvantages
Chromatographic Separation Tools Advantages and DisadvantagesChromatographic Separation Tools Advantages and Disadvantages
Chromatographic Separation Tools Advantages and DisadvantagesRosanne Grace Castor
 
Considering Quality by Design (QbD) in Analytical Development for Protein The...
Considering Quality by Design (QbD) in Analytical Development for Protein The...Considering Quality by Design (QbD) in Analytical Development for Protein The...
Considering Quality by Design (QbD) in Analytical Development for Protein The...Weijun Li
 
Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015KBI Biopharma
 
Graffinity: Novel affinity ligands for downstream processing of proteins
Graffinity: Novel affinity ligands for downstream processing of proteinsGraffinity: Novel affinity ligands for downstream processing of proteins
Graffinity: Novel affinity ligands for downstream processing of proteinsFrank Moffatt
 
Improving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPImproving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPMerck Life Sciences
 
Improving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPImproving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPMilliporeSigma
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmMilliporeSigma
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmMerck Life Sciences
 
Sanket presentation on quality assurance journal club presentation
Sanket presentation on quality assurance journal club presentationSanket presentation on quality assurance journal club presentation
Sanket presentation on quality assurance journal club presentationsanketdaher
 
A brief review on development and validation of hplc method.
A brief review on development and validation of hplc method.A brief review on development and validation of hplc method.
A brief review on development and validation of hplc method.adhirajain
 
HPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDEHPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDESwamiVivekanandaPhar
 
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...
 RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC... RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC...
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...Ajay mandagiri
 
Excipient combinations to manage protein viscosity for highly concentrated fo...
Excipient combinations to manage protein viscosity for highly concentrated fo...Excipient combinations to manage protein viscosity for highly concentrated fo...
Excipient combinations to manage protein viscosity for highly concentrated fo...MilliporeSigma
 
Affinity chromatography: Principles and applications
Affinity chromatography: Principles and applicationsAffinity chromatography: Principles and applications
Affinity chromatography: Principles and applicationsHemant Khandoliya
 
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCSimultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCpharmaindexing
 
Chromatography and types Likhith K
Chromatography and types Likhith KChromatography and types Likhith K
Chromatography and types Likhith KLIKHITHK1
 

Similar to A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity (20)

Prep Symposium | Poster July, 2013
Prep Symposium | Poster July, 2013Prep Symposium | Poster July, 2013
Prep Symposium | Poster July, 2013
 
Process Scale Chromatography
Process Scale ChromatographyProcess Scale Chromatography
Process Scale Chromatography
 
Chromatographic Separation Tools Advantages and Disadvantages
Chromatographic Separation Tools Advantages and DisadvantagesChromatographic Separation Tools Advantages and Disadvantages
Chromatographic Separation Tools Advantages and Disadvantages
 
Method development and validation
Method development and validationMethod development and validation
Method development and validation
 
Considering Quality by Design (QbD) in Analytical Development for Protein The...
Considering Quality by Design (QbD) in Analytical Development for Protein The...Considering Quality by Design (QbD) in Analytical Development for Protein The...
Considering Quality by Design (QbD) in Analytical Development for Protein The...
 
Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015Prep Symposium | Poster July, 2015
Prep Symposium | Poster July, 2015
 
Graffinity: Novel affinity ligands for downstream processing of proteins
Graffinity: Novel affinity ligands for downstream processing of proteinsGraffinity: Novel affinity ligands for downstream processing of proteins
Graffinity: Novel affinity ligands for downstream processing of proteins
 
Improving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPImproving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSP
 
Improving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSPImproving Downstream Processing: Application of Excipients in DSP
Improving Downstream Processing: Application of Excipients in DSP
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Peptide mapping
Peptide mappingPeptide mapping
Peptide mapping
 
Sanket presentation on quality assurance journal club presentation
Sanket presentation on quality assurance journal club presentationSanket presentation on quality assurance journal club presentation
Sanket presentation on quality assurance journal club presentation
 
A brief review on development and validation of hplc method.
A brief review on development and validation of hplc method.A brief review on development and validation of hplc method.
A brief review on development and validation of hplc method.
 
HPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDEHPLC METHOD ADAPALENE & BENZOYL PEROXIDE
HPLC METHOD ADAPALENE & BENZOYL PEROXIDE
 
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...
 RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC... RP_HPLC METHOD   FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND  ITS  PHARMAC...
RP_HPLC METHOD FOR   ESTIMATION  OF BUPROPION HCL IN BULKAND ITS  PHARMAC...
 
Excipient combinations to manage protein viscosity for highly concentrated fo...
Excipient combinations to manage protein viscosity for highly concentrated fo...Excipient combinations to manage protein viscosity for highly concentrated fo...
Excipient combinations to manage protein viscosity for highly concentrated fo...
 
Affinity chromatography: Principles and applications
Affinity chromatography: Principles and applicationsAffinity chromatography: Principles and applications
Affinity chromatography: Principles and applications
 
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLCSimultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
Simultaneous estimation of meclizine and nicotinic acid by using RP-HPLC
 
Chromatography and types Likhith K
Chromatography and types Likhith KChromatography and types Likhith K
Chromatography and types Likhith K
 

More from KBI Biopharma

Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...KBI Biopharma
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...KBI Biopharma
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...KBI Biopharma
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...KBI Biopharma
 
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...KBI Biopharma
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsKBI Biopharma
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...KBI Biopharma
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...KBI Biopharma
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...KBI Biopharma
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaKBI Biopharma
 
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...KBI Biopharma
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesKBI Biopharma
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...KBI Biopharma
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesKBI Biopharma
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationKBI Biopharma
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...KBI Biopharma
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingKBI Biopharma
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...KBI Biopharma
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...KBI Biopharma
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...KBI Biopharma
 

More from KBI Biopharma (20)

Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
Data Collection on the ProteinSimple Maurice: Driving Compliance with the Emp...
 
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
Integration of Cell Line and Process Development to Expedite Delivery of Bisp...
 
High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...High-throughput and Automated Process Development for Accelerated Biotherapeu...
High-throughput and Automated Process Development for Accelerated Biotherapeu...
 
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
Debottlenecking Manufacturing Capacity Using High Seed Density Production Pro...
 
Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...Application and Adaptation of Platform and Alternative Purification Steps to ...
Application and Adaptation of Platform and Alternative Purification Steps to ...
 
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant ProteinsPrimary Recovery & Harvest Processes for non-mAb Recombinant Proteins
Primary Recovery & Harvest Processes for non-mAb Recombinant Proteins
 
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
Compressed Timelines for Breakthrough Therapies: Impact on Process Characteri...
 
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
Speed to GMP: Moving from Rapid Process Development to High Throughput Tech T...
 
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
Implementation of End-to-End Disposable Single Use Systems for Rapid Fermenta...
 
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI BiopharmaHost Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
Host Cell Protein Analysis by Mass Spectrometry | KBI Biopharma
 
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
Handling High Titer Processes and Strategies for DSP Facility Fit | KBI Biop...
 
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation StrategiesOctet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
 
Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
 
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & PossibilitiesHIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
HIV Vaccines Process Development & Manufacturing - Pitfalls & Possibilities
 
Calorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturationCalorimetry study of a mAb that precipitates upon thermal denaturation
Calorimetry study of a mAb that precipitates upon thermal denaturation
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
 
Effects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal UnfoldingEffects of Additives on Reversibility of Thermal Unfolding
Effects of Additives on Reversibility of Thermal Unfolding
 
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
Analysis of Aggregation, Stability, and Lot Comparability by Sedimentation Ve...
 
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
New Software Methods Enhance Sedimentation Velocity Analysis of Protein Aggre...
 
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
Online Size-Exclusion High-Performance Liquid Chromatography Light Scattering...
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxBright Chipili
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexClive Bates
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Catherine Liao
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Catherine Liao
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...kevinkariuki227
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxgauripg8
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgeryKafrELShiekh University
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...Catherine Liao
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...kevinkariuki227
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptxSabbu Khatoon
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesTina Purnat
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxNeurosurgeon Mumtaz Ali Narejo
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsShweta
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Catherine Liao
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptxANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
ANATOMY OF THE LOWER URINARY TRACT AND MALE [Autosaved] [Autosaved].pptx
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
US E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complexUS E-cigarette Summit: Taming the nicotine industrial complex
US E-cigarette Summit: Taming the nicotine industrial complex
 
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
Young at heart: Cardiovascular health stations to empower healthy lifestyle b...
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
TEST BANK For Advanced Practice Nursing in the Care of Older Adults, 2nd Edit...
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
Fundamental of Radiobiology -SABBU.pptx
Fundamental of Radiobiology  -SABBU.pptxFundamental of Radiobiology  -SABBU.pptx
Fundamental of Radiobiology -SABBU.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptxBlue Printing in medical education by Dr.Mumtaz Ali.pptx
Blue Printing in medical education by Dr.Mumtaz Ali.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 

A Comparison of Multimodal Chromatographic Resin: Protein Binding & Selectivity

  • 1. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Leslie S. Wolfe Eric J. Suda Carnley L. Norman Sigma Mostafa Abhinav A. Shukla Process Development & Manufacturing KBI Biopharma, Durham, NC
  • 2. Overview ● Background ○ Mixed Mode Chromatography ○ Mixed Mode Resin characterization ● Comparison of Mixed Mode Resins ○ High throughput method for identifying optimal operating ranges for mixed mode resins ○ Chromatography experiments to characterize HCP and HMW removal ● Conclusions 2
  • 3. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Mixed Mode Chromatography ● Takes advantage of more than one type of interaction ○ i.e. ionic, hydrophobic, hydrogen bonding ● Provides enhanced selectivity, “pseudo-affinity” ● Can reduce process steps ● Several mixed mode resins have recently been developed with: ○ Increased loading capacities ○ Higher ionic strength tolerance GE Healthcare, CaptoTM MMC ligand Ionic interactions Hydrophobic interactions Hydrophobic interactions GE Healthcare, CaptoTM Adhere ligand Ionic interactions Capto is a registered trademark of GE Healthcare 3
  • 4. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Mixed Mode Ligand Examples Pall Corporation NuviaTM cPrimeTM Bio-Rad Laboratories Different mixed mode resins are available on the market and each could potentially result in molecule specific performance (yield and selectivity) EshmunoTM HCX EMD Millipore CaptoTM Adhere GE Healthcare MX-Trp-650M Tosoh CaptoTM MMC GE Healthcare 4 Capto is a registered trademark of GE Healthcare Capto is a registered trademark of GE Healthcare Nuvia and cPrime are registered trademarks of Bio-Rad TOYOPEARL is a registered trademark of Tosoh corporation Eshmuno is a registered trademark of Merck KGaA
  • 5. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Mixed Mode Chromatography potential based on previous work at KBI ● Demonstrated that mixed mode chromatography has the potential of achieving superior selectivity by effectively exploiting multiple properties of a target protein ● Previous work at KBI work focused on characterizing Capto MMC resin and the use of mobile phase modulators to further enhance selectivity ○ Inclusion of Capto MMC into a mAb process was compared with and without selective washes ○ Inclusion of a selective wash on Capto MMC resulted in higher product purity 5 Wolfe, L., Barringer, C., Mostafa, S., Shukla, A. Multimodal chromatography: characterization of protein binding and selectivity enhancement through mobile phase modulators, Journal of Chromatography A, 1340, 151-156, 2014.
  • 6. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Effects of Modulators on Different Proteins ● Resin: Capto MMC ● Modulator added to equilibration, wash and elution buffers ● Products eluted with a linear NaCl gradient ● Impact of modulator on retention was determined by the NaCl concentration at peak maxima 6 Modulator Modulator Effect MgCl2 , NaSCN, KI Decrease hydrophobic interactions Ethanol, Methanol, Isopropanol Decrease hydrophobic interactions (used in low concentrations) Urea, Sodium Thiocyanate Weakens hydrogen bonding, denaturant Glycerol Weakens hydrophobic interactions Ethylene Glycol Weakens hydrophobic interactions and hydrogen bonding Arginine Weakens hydrophobic interactions, induces protein unfolding, disrupts electrostatic interactions Ammonium Sulfate Strengthens hydrophobic interactions Model Protein RNase (pI 8.9) Lysozyme (pI 9.6) mAb1 mAb2 mAb3 mAb4
  • 7. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity 7 Effect of pH on Retention
  • 8. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Log k’ vs. Log [NaCl]: Theory log k’ = A – Blog(csalt ) + C(csalt ) Melander, W.; El Rassi, Z.; Horvath, Cs. Journal of Chromatography, 469, 3-27, 1989. The retention factor under isocratic conditions is represented by: k’ = (tr – tm )/tm tm = time for mobile phase to pass through column tr = target protein retention time Melander et. al described the dependency of the linear retention factor on a mixed mode sorbent as a function of salt concentration as: ● Electrostatic interactions predominate: a linear relationship is expected between log k’ vs log[NaCl] ● Hydrophobic interactions predominate: a linear relationship is expected until a minimum is reached at which point further increases in salt result in increased retention 8
  • 9. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Log k’ vs. Log [NaCl] RNase ● electrostatic interactions ● No effect from urea or ethylene glycol All experiments performed at pH 7.0 Lysozyme ● hydrophobic and electrostatic interactions ● urea has largest effect mAb1 ● driven by electrostatic interactions, hydrophobic contribution ● Urea and arginine have the largest effect 9
  • 10. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Taking Advantage of Modulators ● Incorporation of modulators into process can help increase selectivity and purity of product ● Combinations of modulators can further enhance process step ● Goal: Utilize mobile phase modulators to decrease HCP levels during Capto MMC process step for antibody purification 10
  • 11. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Incorporation of a process step utilizing a modulator wash can improve overall process HCP clearance baseline
  • 12. 12 Overview ● Background ○ Mixed Mode Chromatography ○ Mixed Mode Resin characterization ● Comparison of Mixed Mode Resins ○ High throughput method for identifying optimal operating ranges for mixed mode resins ○ Chromatography experiments to characterize HCP and HMW removal ● Conclusions
  • 13. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Mixed Mode Chromatography & KBI’s mAB Purification Process Platform ● Mixed Mode resins are ideal for KBI’s mAb platform process since by the nature of our business there is a significant diversity in mammalian cell clones/cell culture harvest and mAbs ● Mixed mode resins can provide added robustness to a mAb platform to reduce both HMW and HCP impurities ● Given the complexity of mixed mode resin interactions, optimizing a mixed mode chromatography step can be time consuming and potentially material limiting 13 DS Process Platform Cell Line Diversity Media/feed type diversity HCP level variability Cell Density variability HMW level variability
  • 14. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Objectives ● Determine if there is at least one mixed mode cation exchange/hydrophobic interaction polishing step resin that performs well for multiple mAbs ○ Ideal candidates for a mAb process platform ● Present a high throughput, low material requirement method for identifying optimal operating ranges for multiple mixed mode resins in a single set of experiments ○ Show how the method can be use to identify optimal chromatography conditions ● Show the relationship between the high throughput screening data and chromatography performance for different mAbs 14
  • 15. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Mixed-mode cation exchange/hydrophobic interaction resins 15 NuviaTM cPrimeTM Bio-Rad Laboratories MX-Trp-650M Tosoh EshmunoTM HCX EMD Millipore CaptoTM MMC GE Healthcare TM
  • 16. 16 Overview ● Background ○ Mixed Mode Chromatography ○ Mixed Mode Resin characterization ● Comparison of Mixed Mode Resins ○ High throughput method for identifying optimal operating ranges for mixed mode resins ○ Chromatography experiments to characterize HCP and HMW removal ● Conclusions
  • 17. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity High Throughput Screening: Plate Experimental Design Variable Conditions Evaluated Load pH 4, 5, 6, 7, 8 Elution pH 4, 5, 6, 7, 8 Elution [NaCl] (M) 0.20, 0.65, 1.10, 1.55, 2.00 Three mAbs evaluated under a series of conditions ● One plate executed per load pH 17
  • 18. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity 18 ● The low yield process condition zone size varies significantly with respect to resin, mAbs and process conditions and are easily identifiable ● In general, Capto MMC has slightly larger low yield zones for the mAbs and test conditions within our typical operating pH range . ● In general, each resin has a characteristic surface response map profile
  • 19. 19 Overview ● Background ○ Mixed Mode Chromatography ○ Mixed Mode Resin characterization ● Comparison of Mixed Mode Resins ○ High throughput method for identifying optimal operating ranges for mixed mode resins ○ Chromatography experiments to characterize HCP and HMW removal ● Conclusions
  • 20. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Chromatography Experiments ● Goal: Compare resin ability to reduce HCP and HMW levels at multiple pHs ● Linear gradient studies executed at pH 5, 6 and 7 ○ Product eluted from 0-2M NaCl ○ Each 1/8th CV fractions collected ○ Analyzed fractions by SEC-HPLC for high molecular weight species (HMW) ■ Fractions containing cumulative yield 20%-80% pooled to reduce sample numbers ■ Fractions containing high %LMW were excluded from the cumulative yield vs. cumulative purity analysis ● Fractions containing 0 – 80% product yield after SEC-HPLC analysis were pooled for host cell protein (HCP) analysis 20 Neutralized Protein A pools used for experiments mAb Feed %HMW Feed HCP Level (ppm) mAb1 ~1% 4,395 mAb2 ~4% 135 mAb3 ~8% 3,689
  • 21. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Chromatography Experiments: Elution [NaCl] & elution peak volume data 21 ● In general, Capto MMC and Eshmuno HCX resulted in higher elution volumes ● Nuvia cPrime elution volume changes significantly when pH increases from pH 5.0 to 6.0 ∞ = target protein did not elute during NaCl gradient ● As expected, elution [NaCl] decreases with increasing pH ● Capto MMC and Eshmuno HCX require higher elution [NaCl] at each elution pH ● Tosoh MX-Trp had the lowest elution [NaCl] at each pH and did not vary as much with respect to pH
  • 22. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Cumulative Yield vs. Cumulative HMW mAb Feed %HMW mAb1 ~1% mAb2 ~4% mAb3 ~8% mAb1, pH 5.0 mAb2, pH 5.0 mAb3, pH 5.0 mAb1, pH 6.0 mAb2, pH 6.0 mAb3, pH 6.0 mAb1, pH 7.0 mAb2, pH 7.0 mAb3, pH 7.0
  • 23. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity HCP Reduction ● Not all experiments yielded 80% product in eluate fractions (*). ○ Capto MMC at pH 5.0 did not yield any product for the 3 mAbs tested ○ mAb 3 only achieved 80% yield in 6 of the 12 conditions tested ● HCP clearance is mAb specific with conditions tested. ○ The greatest HCP reduction consistently achieved across the experiments is with mAb 1 mAb Feed HCP Level (ppm) mAb1 4,395 mAb2 135 mAb3 3,689 ** * ** ** * 23
  • 24. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Summary Results – Optimization Factor Resin mAb 1 Optimization Factor (Max. Yield * %HMW Red. * %HCP Red.) mAb 2 Optimization Factor (Max. Yield * %HMW Red. * %HCP Red.) mAb 3 Optimization Factor (Max. Yield * %HMW Red. * %HCP Red.) pH 5.0 Capto MMC N/A* N/A* N/A* Nuvia cPrime 0.81 0.32 N/A** Eshmuno 0.39 N/A** N/A** MX-Trp 0.08 N/A** N/A** pH 6.0 Capto MMC 0.44 0.04 0.39 Nuvia cPrime 0.51 0.26 0.33 Eshmuno 0.08 -0.15 N/A** MX-Trp -0.21 0.11 0.07 pH 7.0 Capto MMC 0.47 0.33 0.31 Nuvia cPrime 0.36 0.22 0.08 Eshmuno 0.29 0.65 N/A** MX-Trp -0.03 0.01 0.14 *mAb did not elute from Capto MMC at pH 5.0 in up to 2M NaCl **Not tested as 80% yield was not achieved 24
  • 25. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Findings regarding the relationship between HT filter plate & chromatography data ● High throughput filter plate data can be used to quickly limit the focus of a chromatography evaluation using minimal amounts of the target protein ○ pH and NaCl conditions not favorable for high yields are easily identifiable ● There is a correlation between yield variability for each condition (load pH and elution pH) and monomer selectivity ○ more variability leads to better selectivity 25
  • 26. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Best resins for each measure & overall performance based on the chromatography experiment results 26 ● There is not one best resin for all mAbs and conditions evaluated ● For each mAb, the best resin for each performance measure varies ● Nuvia cPrime provides good overall performance for all mAbs tested ● Tosoh MX-Trp consistently had low “optimization factor” scores for all of the mAbs and conditions tested *Conclusion will change based on the relative importance of each factor. Molecule Best resins based on yield Best resins based on HMW reduction Best resins based on HCP reduction Overall best resin based on optimization factor mAb1 Capto MMC Tosoh MX-Trp Nuvia cPrime Capto MMC Eshmuno HCX Capto MMC Nuvia cPrime Capto MMC mAb2 Capto MMC Tosoh MX-Trp Eshmuno HCX Nuvia cPrime Eshmuno HCX Capto MMC Eshmuno HCX Nuvia cPrime mAb3 Tosoh MX-Trp Nuvia cPrime Capto MMC Eshmuno HCX Capto MMC Tosoh MX-Trp Capto MMC Nuvia cPrime
  • 27. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Conclusions ● Demonstrated that a high throughput filter plate method can be used as an efficient approach in screening chromatography resins and identifying their optimal process conditions ○ Can assess within a short time period if a resin is suitable for purifying a specific molecule using minimal protein ○ Narrows the focus of chromatography experimental conditions ● Each resin evaluated has its strengths ● Overall performance is based on selecting optimal operating conditions for each resin and mAb combination ○ Nuvia cPrime provides good overall performance for all mAbs tested ○ Backup options will be needed to meet the unique challenges of each mAb 27
  • 28. A Comparison of Multimodal Chromatographic Resins: Protein Binding & Selectivity Acknowledgments • Eric Suda • Abhinav Shukla, Ph.D. • Sigma Mostafa, Ph.D. • Carnley Norman, Ph.D. • KBI Process Development Team • KBI Analytical Development Team 28
  • 29. www.kbibiopharma.com PO Box 15579 1101 Hamlin Road Durham, NC 27704 Tel: +1 919 479 9898 Contact Us